Funding Opportunity: Comprehensive Geriatric Assessment (CGA)

Mixed consortia of robot manufacturers and research institutes have the opportunity to apply for a total funding of 1.2 million Euros in a competitive process in order to develop small-scale test series as solutions for the given challenge. AQuAS (Agència de Qualitat I Avaluació Sanitàries de Catalunya), a public entity of the Catalan Department of Health, and Fundació Privada Sant Antoni Abat, a non-profit private foundation managing and developing innovation and research in healthcare, have defined the Comprehensive Geriatric Assessment (CGA) challenge. This challenge specifies the requirements of the public bodies for a robotic product that is not yet available on the market.

The Comprehensive Geriatric Assessment (CGA) is a diagnostic instrument designed to collect data on the medical, psychosocial and functional resources and problems of elderly patients. The information gathered is used to create a plan for treatment and followup. Currently, CGA is performed by social and clinical professionals involved in the care of elderly people: physiotherapists, occupational therapists, nurses, social workers, psychologists, medical doctors, etc. The goal of utilizing a robot to control and to conduct the geriatric tests is to reduce the amount of time medical professionals spend on taking tests and thereby enable them to invest this time oncare planning decisions. In order to master this challenge, multi-institutional consortia or development teams will need to apply for funding in a competitive process in order to develop prototypes according to the needs of the public bodies.

The aim of ECHORD++ (European Clearing House for Open Robotics Development Plus Plus) is to strengthen the knowledge transfer between scientific research, industry and users in robotics and to stimulate their cooperation. The EU-funded project with a runtime of five years (2013 - 2018) funds small-scale research projects called experiments, Public end-user Driven Technological Innovation (PDTI), and established Robotics Innovation Facilities (RIFs), open labs which provide state-of-the-art robotic hardware and software as well as scientific and technical support. ECHORD++ is a joint project of Technische Universität München (project coordinator), Blue Ocean Robotics, Bristol Robotics Laboratory, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, R.U. Robots, Scuola Superiore Sant’Anna, TechnoDeal and Universitat Politècnica de Catalunya.

The idea behind Public end-user Driven Technological Innovation (PDTI) in ECHORD++ is to include public bodies in the robotic product development. By acting as technologically demanding first buyers, public procurers can drive innovation from the demand side and promote the transfer of robotic technology from research to the market. Since public bodies often have specific requirements for the products they use, ECHORD++ will strive to find the best way to integrate them in the product development process. This is to make sure that the product meets the requirements of the target group, technically and price-wise. Thus, ECHORD++ hopes to close the innovation gap between what is available on the market and the public sector's needs.

Closing date: 23rd June 2015

For further information about PDTI, please visit:
http://www.echord.eu/pdti/

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Tel.: +49 89 289 18136

The project ECHORD++ is funded under EU’s Seventh Framework Programme for Research (FP7), Grant Agreement No. 601116.

Most Popular Now

Artificial Intelligence Solution Improve…

Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of...

South West London Pathology Picks CliniS…

One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a...

Call for Tenders: Studies on eHealth, In…

The European Commission is launching a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU, in particular with...

AI-based AI-Rad Companion Chest CT Softw…

AI-Rad Companion Chest CT(1), an intelligent software assistant for radiology, was recently awarded the CE mark, which means Siemens Healthineers can start marketing this artificial intelligence (AI)-based software as a...

Spot On for Healthcare Technology Startu…

10 - 12 October 2019, Berlin, Germany. XPOMET Medicinale brings together care providers, patients, and in general stakeholders from all health-related fields and geographic regions. The Festival of Future Medicine and...

Isansys Named as Finalist for OBN's Most…

Isansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake...

7th MEDICA MEDICINE + SPORTS CONFERENCE

18 - 21 November 2019, Düsseldorf, Germany. What lengths do top athletes go to in order to reach peak performances and which findings in the field of professional sports are relevant...

How can We Successfully Converge the Hea…

Opinion Article by Erik Janssen, VP, Innovative Solutions, Neurology, UCB Pharma. The fourth industrial revolution is upon us and fundamentally changing the way we live, work and interact across all industries...

Carestream Health Completes Sale of Heal…

Carestream Healthhas completed the sale of the company's healthcare information solutions business to Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in 26 of the 38...

Allscripts Listed on Lot One of Health S…

Allscripts has been included on a new list of accredited suppliers of electronic patient records that has been published by NHS England and NHSX. The company is one of just...